Funding for this research was provided by:
Cancer Research UK (C1287/A16563, C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565)
European Union's Horizon 2020 Research and Innovation Programme (634935, 633784)
European Community´s Seventh Framework Programme (HEALTH-F2-2009-223175)
National Institutes of Health (CA148065, CA128978, 1U19 CA148537, 1U19 CA148065 and 1U19 CA148112)
KWF Kankerbestrijding (2015-7632)
Received: 15 May 2020
Accepted: 25 September 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: The study was performed in accordance with the Declaration of Helsinki. Summary estimates were used from previously reported studies that followed the appropriate institutional review and patient consent procedures and followed the procedure the Data Access Coordination Committee (DACC) of BCAC (ExternalRef removed).
: Not applicable.
: The authors declare no competing interests.